Vaccinomics: Current findings, challenges and novel approaches for vaccine development

AAPS Journal

Volumn 13, Issue 3, 2011, Pages 438-444

  Ovsyannikova, Inna G ^a,b   Poland, Gregory A ^a,b  

^a MAYO CLINIC   (United States)

^b Program in Translational Immunovirology and Biodefense   (United States)

Author keywords

genetic association; HLA; immunogenetics; polymorphisms; SNPs; vaccines; vaccinomics

Indexed keywords

INFLUENZA VACCINE; INTERLEUKIN 6; MEASLES MUMPS RUBELLA VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; TOLL LIKE RECEPTOR; VIRUS VACCINE; YELLOW FEVER VACCINE;

ADAPTIVE IMMUNITY; DRUG RESPONSE; GENE FUNCTION; GENETIC ASSOCIATION; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN LEUKOCYTE ANTIGEN GENE; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNOGENETICS; INNATE IMMUNITY; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TOLL LIKE RECEPTOR GENE; TRIM5 GENE; VACCINATION; VACCINE PRODUCTION;

ADAPTIVE IMMUNITY; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; HLA ANTIGENS; HUMANS; IMMUNITY, INNATE; IMMUNOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; VACCINES;

EID: 80052599857     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-011-9281-x     Document Type: Review

References (63)

1. GA Poland 2007 Pharmacology, vaccinomics, and the second golden age of vaccinology Clin Pharmacol Ther 82 6 623 626 17998905 10.1038/sj.clpt.6100379 1:STN:280:DC%2BD2snntlKhug%3D%3D (Pubitemid 350114819)
2. GA Poland IG Ovsyannikova RM Jacobson DI Smith 2007 Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics Clin Pharmacol Ther 82 6 653 664 17971814 10.1038/sj.clpt.6100415 1:CAS:528:DC%2BD2sXht1ymu7vN (Pubitemid 350114830)
3. GA Poland IG Ovsyannikova RM Jacobson 2008 Personalized vaccines: the emerging field of vaccinomics Expert Opin Biol Ther 8 11 1659 1667 18847302 10.1517/14712598.8.11.1659 1:CAS:528:DC%2BD1cXht1artrfI
4. A Marchant M Pihlgren T Goetghebuer HA Weiss MO Ota SE Schlegel-Hauter, et al. 2006 Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants J Infect Dis 193 11 1598 1605 16652290 10.1086/503775 (Pubitemid 43794590)
5. RM Jacobson IG Ovsyannikova PV Targonski GA Poland 2007 Studies of twins in vaccinology Vaccine 25 16 3160 3164 17284336 10.1016/j.vaccine.2007.01.048 (Pubitemid 46482759)
6. PL Tan RM Jacobson GA Poland SJ Jacobsen SV Pankratz 2001 Twin studies of immunogenicity-determining the genetic contribution to vaccine failure Vaccine 19 2434 2439 11257374 10.1016/S0264-410X(00)00468-0 1:STN:280: DC%2BD3MvgvFSqsQ%3D%3D (Pubitemid 32234254)
7. MJ Newport T Goetghebuer HA Weiss 2004 The MRC Gambia Twin Study Group, Whittle H, Siegrist C-A, et al. Genetic regulation of immune responses to vaccines in early life Genes Immun 5 2 122 129 14737096 10.1038/sj.gene.6364051 1:CAS:528:DC%2BD2cXhslCgs7s%3D (Pubitemid 38967641)
8. GA Poland RM Jacobson IG Ovsyannikova 2009 Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine and consumer culture and vaccinomics Vaccine 27 25-26 3240 3244 19200833 10.1016/j.vaccine.2009.01.069
9. GA Poland IG Ovsyannikova RM Jacobson 2009 Application of pharmacogenomics to vaccines Pharmacogenomics 10 5 837 852 19450131 10.2217/pgs.09.25 1:CAS:528:DC%2BD1MXmtVahsLc%3D
10. T Hohler G Gerken A Notghi R Lubjuhn H Taheri U Protzer, et al. 1997 HLA-DRB1 1301 and 1302 protect against chronic hepatitis B J Hepatol 26 3 503 507 9075656 10.1016/S0168-8278(97)80414-X 1:STN:280:DyaK2s3jtVSkug%3D%3D (Pubitemid 27112714)
11. CM Gelder R Lambkin KW Hart D Fleming OM Williams M Bunce, et al. 2002 Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine J Infect Dis 185 114 117 11756990 10.1086/338014 1:CAS:528: DC%2BD38XmvFaisg%3D%3D (Pubitemid 34043025)
12. IG Ovsyannikova RM Jacobson RA Vierkant SV Pankratz SJ Jacobsen GA Poland 2004 Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination Vaccine 22 1914 1920 15121303 10.1016/j.vaccine.2003.11.016 1:CAS:528:DC%2BD2cXjs1Cns7Y%3D (Pubitemid 38581060)
13. GA Poland IG Ovsyannikova RM Jacobson 2008 Immunogenetics of seasonal influenza vaccine response Vaccine 26S D35 D40 10.1016/j.vaccine.2008.07.065
14. RM Jacobson GA Poland RA Vierkant VS Pankratz DJ Schaid SJ Jacobsen, et al. 2003 The association of class I HLA alleles and antibody levels following a single dose of measles vaccine Hum Immunol 64 1 103 109 12507820 10.1016/S0198-8859(02)00741-3 1:CAS:528:DC%2BD38XpvVajur8%3D (Pubitemid 36109818)
15. IG Ovsyannikova VS Pankratz RA Vierkant RM Jacobson GA Poland 2006 Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine J Infect Dis 193 5 655 663 16453260 10.1086/500144 1:CAS:528:DC%2BD28XitF2ht7Y%3D (Pubitemid 43273493)
16. IG Ovsyannikova RM Jacobson RA Vierkant MM O'Byrne GA Poland 2009 Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations Vaccine 27 49 6926 6931 19761839 10.1016/j.vaccine.2009.08.109 1:CAS:528:DC%2BD1MXhtlCmsL%2FF
17. IG Ovsyannikova RM Jacobson RA Vierkant SJ Jacobsen VS Pankratz GA Poland 2004 The contribution of HLA class I antigens in immune status following two doses of rubella vaccination Hum Immunol 65 1506 1515 15603879 10.1016/j.humimm.2004.07.001 1:CAS:528:DC%2BD2cXhtVyqs77M (Pubitemid 39643231)
18. IG Ovsyannikova RM Jacobson N Dhiman RA Vierkant VS Pankratz GA Poland 2008 Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine Pediatrics 121 e1091 e1099 18450852 10.1542/peds.2007-1575
19. IG Ovsyannikova JE Ryan RA Vierkant MM O'Byrne RM Jacobson GA Poland 2009 Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination Vaccine 27 3359 3366 19200845 10.1016/j.vaccine.2009.01.079 1:CAS:528:DC%2BD1MXmtlKgu7w%3D
20. DJ Schaid CM Rowland DE Tines RM Jacobson GA Poland 2002 Score tests for association between traits and haplotypes when linkage phase is ambiguous Am J Hum Genet 70 425 434 11791212 10.1086/338688 (Pubitemid 34112296)
21. IG Ovsyannikova RA Vierkant VS Pankratz RM Jacobson GA Poland 2010 Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity PLoS ONE 5 7 e11806 20668555 10.1371/journal.pone.0011806
22. GA Poland IG Ovsyannikova RM Jacobson 2008 Vaccine immunogenetics: bedside to bench to population Vaccine 26 6183 6188 18598732 10.1016/j.vaccine.2008.06.057 1:CAS:528:DC%2BD1cXhtlCrurfF
23. Poland GA, Ovsyannikova IG, Jacobson RM. Genetics and immune response to vaccines. In: Kaslow RA, McNicholl JM, Hill AVS, editors. Genetic susceptibility to infectious diseases. New York, New York: Oxford University Press; 2008. p. 414-29.
24. T Hohler E Reuss N Evers E Dietrich C Rittner CM Freitag, et al. 2002 Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins Lancet 360 9338 991 995 12383669 10.1016/S0140-6736(02)11083-X (Pubitemid 35284111)
25. N Dhiman IH Haralambieva RB Kennedy RA Vierkant MM O'Byrne IG Ovsyannikova, et al. 2010 Assesment of SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccination Immunogenetics 62 4 197 210 20217072 10.1007/s00251-010-0423-6 1:CAS:528:DC%2BC3cXjs1Omsr8%3D
26. P Jin E Wang 2003 Polymorphism in clinical immunology-from HLA typing to immunogenetic profiling J Transl Med 1 1 8 14624696 10.1186/1479-5876-1-8 (Pubitemid 39130339)
27. LP Perera TA Waldmann JD Mosca N Baldwin JA Berzofsky SK Oh 2007 Development of smallpox vaccine candidates with integrated IL-15 that demonstrate superior immunogenicity, efficacy and safety in mice J Virol 81 16 8774 8783 17553867 10.1128/JVI.00538-07 1:CAS:528:DC%2BD2sXoslOitLk%3D (Pubitemid 47242850)
28. LJ Keen 2002 The extent and analysis of cytokine and cytokine receptor gene polymorphism Transpl Immunol 10 2-3 143 146 12216945 10.1016/S0966-3274(02) 00061-8 1:CAS:528:DC%2BD38XlvVenur8%3D
29. IG Ovsyannikova IH Haralambieva N Dhiman MM O'Byrne VS Pankratz RM Jacobson, et al. 2010 Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination J Infect Dis 201 2 207 213 20001730 10.1086/649588 1:CAS:528:DC%2BC3cXhvFSmsrs%3D
30. SL Sawyer LI Wu JM Akey M Emerman HS Malik 2006 High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans Curr Biol 16 1 95 100 16401428 10.1016/j.cub.2005.11.045 1:CAS:528:DC%2BD28XksVahuw%3D%3D (Pubitemid 43049892)
31. D van Manen MA Rits C Beugeling K van Dort H Schuitemaker NA Kootstra 2008 The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection PLoS Pathog 4 2 e18 18248091 10.1371/journal.ppat.0040018 (Pubitemid 351340720)
32. IG Ovsyannikova N Dhiman IH Haralambieva RA Vierkant MM O'Byrne RM Jacobson, et al. 2010 Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes Hum Genet 127 207 221 19902255 10.1007/s00439-009-0763-1 1:CAS:528:DC%2BC3cXlslWqsw%3D%3D
33. AG Bowie IR Haga 2005 The role of Toll-like receptors in the host response to viruses Mol Immunol 42 8 859 867 15829275 10.1016/j.molimm.2004.11. 007 1:CAS:528:DC%2BD2MXjtFOmsbg%3D (Pubitemid 40489009)
34. H Javanbakht P An B Gold DC Petersen C O'Huigin GW Nelson, et al. 2006 Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection Virology 354 1 15 27 16887163 10.1016/j.virol.2006.06.031 1:CAS:528:DC%2BD28XhtVWqtLrI (Pubitemid 44468115)
35. V Goldschmidt G Bleiber M May R Martinez M Ortiz A Telenti 2006 Role of common human TRIM5alpha variants in HIV-1 disease progression Retrovirology 3 54 16925802 10.1186/1742-4690-3-54 (Pubitemid 44377740)
36. IH Haralambieva N Dhiman IG Ovsyannikova RA Vierkant VS Pankratz RM Jacobson, et al. 2010 2′-5′-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine Hum Immunol 71 4 383 391 20079393 10.1016/j.humimm.2010.01.004 1:CAS:528:DC%2BC3cXjs1WqtrY%3D
37. V Mata-Haro C Cekic M Martin PM Chilton CR Casella TC Mitchell 2007 The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4 Science 316 5831 1628 1632 17569868 10.1126/science.1138963 1:CAS:528: DC%2BD2sXmtl2jsLk%3D (Pubitemid 46982038)
38. YF Lau LH Tang EE Ooi 2009 A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic Vaccine 27 9 1354 1364 19150474 10.1016/j.vaccine.2008.12.048 1:CAS:528:DC%2BD1MXhvF2it7g%3D
39. CL Cooper HL Davis ML Morris SM Efler MA Adhami AM Krieg, et al. 2004 CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study J Clin Immunol 24 6 693 701 15622454 10.1007/s10875-004-6244-3 1:CAS:528: DC%2BD2MXhtFSmsQ%3D%3D (Pubitemid 40933121)
40. IM Belyakov D Isakov Q Zhu A Dzutsev D Klinman JA Berzofsky 2006 Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host J Immunol 177 9 6336 6343 17056564 1:CAS:528:DC%2BD28XhtFSns7jP (Pubitemid 44628852)
41. TA Manolio LD Brooks FS Collins 2008 A HapMap harvest of insights into the genetics of common disease J Clin Invest 118 5 1590 1605 18451988 10.1172/JCI34772 1:CAS:528:DC%2BD1cXlsF2nt7w%3D (Pubitemid 351632361)
42. JN Hirschhorn MJ Daly 2005 Genome-wide association studies for common diseases and complex traits Genetics 6 95 108 15716906 1:CAS:528: DC%2BD2MXhtFyjsr8%3D (Pubitemid 40179532)
43. BW Igl IR Konig A Ziegler 2009 What do we mean by 'replication' and 'validation' in genome-wide association studies? Hum Hered 67 1 66 68 18931511 10.1159/000164400
44. SJ Chanock T Manolio M Boehnke E Boerwinkle DJ Hunter G Thomas, et al. 2007 Replicating genotype-phenotype associations Nature 447 7145 655 660 17554299 10.1038/447655a 1:CAS:528:DC%2BD2sXmtFemur4%3D (Pubitemid 46889722)
45. TD Querec RS Akondy EK Lee W Cao HI Nakaya D Teuwen, et al. 2009 Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans Nat Immunol 10 1 116 125 19029902 10.1038/ni.1688 1:CAS:528:DC%2BD1cXhsVWhu73J
46. N Dhiman DI Smith GA Poland 2009 Next-generation sequencing: a transformative tool for vaccinology Expert Rev Vaccine 8 8 963 967 10.1586/erv.09.67 1:CAS:528:DC%2BD1MXovFOls7c%3D
47. IG Ovsyannikova RM Jacobson RA Vierkant VS Pankratz GA Poland 2007 HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design Vaccine 25 16 3090 3100 17280755 10.1016/j.vaccine.2007.01.020 1:CAS:528:DC%2BD2sXjslSrsLw%3D (Pubitemid 46482739)
48. IG Ovsyannikova RA Vierkant VS Pankratz MM O'Byrne RM Jacobson GA Poland 2009 HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine Vaccine 27 3349 3358 19200828 10.1016/j.vaccine.2009.01.080 1:CAS:528:DC%2BD1MXmtlKgu78%3D
49. P Sinha JA Snyder EY Kim KD Moudgil 2007 The major histocompatibility complex haplotypes dictate and the background genes fine-tune the dominant versus the cryptic response profile of a T-cell determinant within a native antigen: relevance to disease susceptibility and vaccination Scand J Immunol 65 2 158 165 17257220 10.1111/j.1365-3083.2006.01891.x 1:STN:280: DC%2BD2s%2FlsVanuw%3D%3D (Pubitemid 46174923)
50. B Halassy S Mateljak FB Bouche MM Putz CP Muller R Frkanec, et al. 2006 Immunogenicity of peptides of measles virus origin and influence of adjuvants Vaccine 24 2 185 194 16122851 10.1016/j.vaccine.2005.07.057 1:CAS:528: DC%2BD2MXht12qurnN (Pubitemid 41753006)
51. MM Putz W Ammerlaan F Schneider G Jung CP Muller 2004 Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens Vaccine 22 31-32 4173 4182 15474707 10.1016/j.vaccine.2004. 06.013 (Pubitemid 39330339)
52. V Pasquetto HH Bui R Giannino F Mirza J Sidney C Oseroff, et al. 2005 HLA-A 0201, HLA-A 1101, and HLA-B 0702 Transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products J Immunol 175 8 5504 5515 16210659 1:CAS:528:DC%2BD2MXhtVyltr%2FK (Pubitemid 41456438)
53. SP Spielberg 1998 Therapeutics and toxicology Curr Opin Pediatr 10 201 202 9608900 10.1097/00008480-199804000-00015 1:STN:280:DyaK1c3ntFyktg%3D%3D (Pubitemid 28256721)
54. K Vandenbroeck A Goris 2003 Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy? Trends Pharmacol Sci 24 6 284 289 12823954 10.1016/S0165-6147(03)00131-7 1:CAS:528:DC%2BD3sXkvVCms7w%3D (Pubitemid 36725003)
55. Kaslow RA, McNicholl JM, Hill AVS. Genetic susceptibility to infectious diseases. New York: Oxford University Press; 2008.
56. KL Johnson IG Ovsyannikova CJ Mason HR Bergen III GA Poland 2009 Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development Vaccine 28 1 38 47 19822231 10.1016/j.vaccine.2009.09.126
57. KL Johnson IG Ovsyannikova G Poland DC Muddiman 2005 Identification of class II HLA-DRB1 03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry J Proteome Res 4 2243 2249 16335972 10.1021/pr0501416 1:CAS:528:DC%2BD2MXhtFWrsrbN (Pubitemid 41814293)
58. IG Ovsyannikova KL Johnson S Naylor DC Muddiman GA Poland 2003 Naturally processed measles virus peptide eluted from class II HLA-DRB1 03 recognized by T lymphocytes from human blood Virology 312 2 495 506 12919753 10.1016/S0042-6822(03)00281-2 1:CAS:528:DC%2BD3sXmt1eguro%3D (Pubitemid 36960023)
59. IG Ovsyannikova KL Johnson DC Muddiman RA Vierkant GA Poland 2004 Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides J Virol 78 1 42 51 14671086 10.1128/JVI.78.1.42-51. 2004 1:CAS:528:DC%2BD3sXhtVWnsrnO (Pubitemid 37549718)
60. C Wang J Tang W Song E Lobashevsky CM Wilson RA Kaslow 2004 HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination Hepatology 39 4 978 988 15057902 10.1002/hep.20142 1:CAS:528:DC%2BD2cXjtlCqsrk%3D (Pubitemid 38428937)
61. M-J Kim AN Nafziger CD Harro HL Keyserling KM Ramsey GL Drusano, et al. 2003 Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response Vaccine 21 11-12 1174 1179 12559795 10.1016/S0264-410X(02)00626-6 1:CAS:528:DC%2BD3sXmt1aisA%3D%3D (Pubitemid 36139946)
62. HG Lee J-S Lim K-Y Lee Y-K Choi I-S Choe T-W Chung, et al. 1997 Peptide-specific CTL induction in HBV-seropositive PBMC by stimulation with peptides in vitro: novel epitopes identified from chronic carriers Virus Res 50 185 194 9282783 10.1016/S0168-1702(97)00068-3 1:CAS:528:DyaK2sXlslKnsLY%3D (Pubitemid 27374781)
63. N Dhiman JM Cunningham RM Jacobson RA Vierkant Y Wu IG Ovsyannikova, et al. 2007 Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors J Allergy Clin Immunol 120 3 666 672 17560639 10.1016/j.jaci.2007.04.036 1:CAS:528:DC%2BD2sXhtVSgsb%2FK (Pubitemid 47320741)